世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Antibody Discovery Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
The Antibody Discovery Market is projected to experience notable growth, fueled by advancements and innovations in the pharmaceutical and biotechnology industries. Utilizing modern techniques such ... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe Antibody Discovery Market is projected to experience notable growth, fueled by advancements and innovations in the pharmaceutical and biotechnology industries. Utilizing modern techniques such as phage display and hybridoma technology, the sector aims to create targeted and efficient therapeutic solutions. These advancements are pivotal in tackling challenging diseases, including cancer, autoimmune conditions, and infectious ailments.Market Insights The global Antibody Discovery Market is expected to maintain steady expansion, reaching a valuation of $8.88 billion by 2025 and $15.82 billion by 2032, growing at a CAGR of 8.60% during the forecast period. This growth underscores the market's critical role in developing precise and effective therapeutic solutions. The integration of artificial intelligence and personalized medicine further drives innovation and opens new revenue avenues. Key Market Drivers 1. Biotechnology Innovations: Advanced technologies, such as next-generation sequencing and sophisticated screening methods, are transforming antibody discovery. These improvements enhance efficiency, enabling rapid identification of viable therapeutic antibodies. 2. Demand for Personalized Medicine: The trend toward tailored treatments is accelerating, boosting the need for customized antibody-based solutions. This shift aligns with the growing emphasis on precision medicine, which prioritizes patient-specific disease management. 3. Rising Chronic Disease Incidence: Increasing cases of cancer, autoimmune disorders, and other long-term illnesses highlight the necessity for innovative therapeutic approaches, placing antibody discovery at the forefront of medical advancements. Business Opportunities 1. Collaborative Ventures: Strategic alliances with universities, biotech firms, and research organizations offer immense potential. These partnerships enhance resource utilization and expedite the development of innovative therapeutic antibodies. 2. AI Integration: Employing artificial intelligence in antibody design, screening, and optimization accelerates the discovery of high-specificity antibodies. Such technological advancements provide a competitive advantage to market participants. 3. Growth in South Asia & Pacific: Increased research funding and collaborative efforts in countries such as India, China, and Australia are fostering the region’s emergence as a hub for antibody discovery. Regional Analysis • Europe: With its robust research ecosystem and supportive regulatory framework, Europe is becoming a dominant region in the market. The region’s streamlined approval processes and focus on innovation drive significant investment and growth. • North America: As a global leader in biotechnology and pharmaceutical research, North America’s advanced infrastructure and funding capabilities make it a critical player in market expansion. • South Asia & Pacific: The region is witnessing rapid growth due to increased biomedical research activities and collaborations addressing complex diseases, strengthening its position in the global Analysis. Market Challenges 1. Regulatory Constraints: Strict regulatory requirements for the development and approval of antibody-based therapeutics can delay market progress. Adhering to these frameworks is essential for maintaining market trust and credibility. 2. Technological Integration Hurdles: The complexity of harmonizing various antibody discovery technologies, such as phage display and hybridoma, demands significant expertise and investment, presenting ongoing challenges. Recent Developments 1. Expanded Collaborations: In 2023, Regeneron Pharmaceuticals, Inc., and Intellia Therapeutics, Inc., enhanced their partnership to focus on CRISPR-based gene-editing therapies for neurological and muscular disorders. 2. Enhanced Research Initiatives: Abzena’s strategic move in 2022 to bolster its Cambridge research facilities highlights its commitment to advancing biologics and antibody drug conjugates. Key Players Leading companies contributing to advancements in the Antibody Discovery Market include: • Alcami Corporation, Inc. • BASF SE • Bioduro-Sundia • Bruker • Cambrex Corporation • Croda International Plc • Aragen Life Sciences Pvt. Ltd • Eurofins DiscoverX Corporation • NanoCellect Biomedical • Sartorius AG Market Segmentation 1. By Method: o Phage Display o Hybridoma o Others 2. By Antibody Type: o Humanized Antibody o Human Antibody o Chimeric Antibody o Murine Antibody 3. By End-Use: o Pharmaceutical and Biotechnology Industry o Research Laboratory o Academic Laboratory 4. By Region: o North America o Europe o East Asia o South Asia & Oceania o Latin America o Middle East & Africa Table of Contents1. Executive Summary1.1. Global Antibody Discovery Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value, 2025 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. Porter’s Five Forces Analysis 2.5. COVID-19 Impact Analysis 2.5.1. Supply 2.5.2. Demand 2.6. Impact of Ukraine-Russia Conflict 2.7. Economic Overview 2.7.1. World Economic Projections 2.8. PESTLE Analysis 3. Global Antibody Discovery Market Outlook, 2019 - 2032 3.1. Global Antibody Discovery Market Outlook, by Method, Value (US$ Bn), 2019 - 2032 3.1.1. Key Highlights 3.1.1.1. Phage Display 3.1.1.2. Hybridoma 3.1.1.3. Others 3.2. Global Antibody Discovery Market Outlook, by Antibody Type, Value (US$ Bn), 2019 - 2032 3.2.1. Key Highlights 3.2.1.1. Humanized Antibody 3.2.1.2. Human Antibody 3.2.1.3. Chimeric Antibody 3.2.1.4. Murine Antibody 3.3. Global Antibody Discovery Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032 3.3.1. Key Highlights 3.3.1.1. Pharmaceutical and Biotechnology industry 3.3.1.2. Research laboratory 3.3.1.3. Academic laboratory 3.4. Global Antibody Discovery Market Outlook, by Region, Value (US$ Bn), 2019 - 2032 3.4.1. Key Highlights 3.4.1.1. North America 3.4.1.2. Europe 3.4.1.3. Asia Pacific 3.4.1.4. Latin America 3.4.1.5. Middle East & Africa 4. North America Antibody Discovery Market Outlook, 2019 - 2032 4.1. North America Antibody Discovery Market Outlook, by Method, Value (US$ Bn), 2019 - 2032 4.1.1. Key Highlights 4.1.1.1. Phage Display 4.1.1.2. Hybridoma 4.1.1.3. Others 4.2. North America Antibody Discovery Market Outlook, by Antibody Type, Value (US$ Bn), 2019 - 2032 4.2.1. Key Highlights 4.2.1.1. Humanized Antibody 4.2.1.2. Human Antibody 4.2.1.3. Chimeric Antibody 4.2.1.4. Murine Antibody 4.3. North America Antibody Discovery Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032 4.3.1. Key Highlights 4.3.1.1. Pharmaceutical and Biotechnology industry 4.3.1.2. Research laboratory 4.3.1.3. Academic laboratory 4.3.2. BPS Analysis/Market Attractiveness Analysis 4.4. North America Antibody Discovery Market Outlook, by Country, Value (US$ Bn), 2019 - 2032 4.4.1. Key Highlights 4.4.1.1. Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 4.4.1.2. Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 4.4.1.3. Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 4.4.1.4. Canada Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 4.4.1.5. Canada Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 4.4.1.6. Canada Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 4.4.2. BPS Analysis/Market Attractiveness Analysis 5. Europe Antibody Discovery Market Outlook, 2019 - 2032 5.1. Europe Antibody Discovery Market Outlook, by Method, Value (US$ Bn), 2019 - 2032 5.1.1. Key Highlights 5.1.1.1. Phage Display 5.1.1.2. Hybridoma 5.1.1.3. Others 5.2. Europe Antibody Discovery Market Outlook, by Antibody Type, Value (US$ Bn), 2019 - 2032 5.2.1. Key Highlights 5.2.1.1. Humanized Antibody 5.2.1.2. Human Antibody 5.2.1.3. Chimeric Antibody 5.2.1.4. Murine Antibody 5.3. Europe Antibody Discovery Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032 5.3.1. Key Highlights 5.3.1.1. Pharmaceutical and Biotechnology industry 5.3.1.2. Research laboratory 5.3.1.3. Academic laboratory 5.3.2. BPS Analysis/Market Attractiveness Analysis 5.4. Europe Antibody Discovery Market Outlook, by Country, Value (US$ Bn), 2019 - 2032 5.4.1. Key Highlights 5.4.1.1. Germany Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 5.4.1.2. Germany Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 5.4.1.3. Germany Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 5.4.1.4. U.K. Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 5.4.1.5. U.K. Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 5.4.1.6. U.K. Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 5.4.1.7. France Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 5.4.1.8. France Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 5.4.1.9. France Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 5.4.1.10. Italy Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 5.4.1.11. Italy Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 5.4.1.12. Italy Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 5.4.1.13. Turkey Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 5.4.1.14. Turkey Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 5.4.1.15. Turkey Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 5.4.1.16. Russia Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 5.4.1.17. Russia Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 5.4.1.18. Russia Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 5.4.1.19. Rest of Europe Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 5.4.1.20. Rest of Europe Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 5.4.1.21. Rest of Europe Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 5.4.2. BPS Analysis/Market Attractiveness Analysis 6. Asia Pacific Antibody Discovery Market Outlook, 2019 - 2032 6.1. Asia Pacific Antibody Discovery Market Outlook, by Method, Value (US$ Bn), 2019 - 2032 6.1.1. Key Highlights 6.1.1.1. Phage Display 6.1.1.2. Hybridoma 6.1.1.3. Others 6.2. Asia Pacific Antibody Discovery Market Outlook, by Antibody Type, Value (US$ Bn), 2019 - 2032 6.2.1. Key Highlights 6.2.1.1. Humanized Antibody 6.2.1.2. Human Antibody 6.2.1.3. Chimeric Antibody 6.2.1.4. Murine Antibody 6.3. Asia Pacific Antibody Discovery Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032 6.3.1. Key Highlights 6.3.1.1. Pharmaceutical and Biotechnology industry 6.3.1.2. Research laboratory 6.3.1.3. Academic laboratory 6.3.2. BPS Analysis/Market Attractiveness Analysis 6.4. Asia Pacific Antibody Discovery Market Outlook, by Country, Value (US$ Bn), 2019 - 2032 6.4.1. Key Highlights 6.4.1.1. China Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 6.4.1.2. China Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 6.4.1.3. China Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 6.4.1.4. Japan Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 6.4.1.5. Japan Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 6.4.1.6. Japan Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 6.4.1.7. South Korea Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 6.4.1.8. South Korea Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 6.4.1.9. South Korea Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 6.4.1.10. India Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 6.4.1.11. India Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 6.4.1.12. India Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 6.4.1.13. Southeast Asia Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 6.4.1.14. Southeast Asia Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 6.4.1.15. Southeast Asia Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 6.4.1.16. Rest of Asia Pacific Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 6.4.1.17. Rest of Asia Pacific Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 6.4.1.18. Rest of Asia Pacific Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 6.4.2. BPS Analysis/Market Attractiveness Analysis 7. Latin America Antibody Discovery Market Outlook, 2019 - 2032 7.1. Latin America Antibody Discovery Market Outlook, by Method, Value (US$ Bn), 2019 - 2032 7.1.1. Key Highlights 7.1.1.1. Phage Display 7.1.1.2. Hybridoma 7.1.1.3. Others 7.2. Latin America Antibody Discovery Market Outlook, by Antibody Type, Value (US$ Bn), 2019 - 2032 7.2.1. Key Highlights 7.2.1.1. Humanized Antibody 7.2.1.2. Human Antibody 7.2.1.3. Chimeric Antibody 7.2.1.4. Murine Antibody 7.3. Latin America Antibody Discovery Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032 7.3.1. Key Highlights 7.3.1.1. Pharmaceutical and Biotechnology industry 7.3.1.2. Research laboratory 7.3.1.3. Academic laboratory 7.3.2. BPS Analysis/Market Attractiveness Analysis 7.4. Latin America Antibody Discovery Market Outlook, by Country, Value (US$ Bn), 2019 - 2032 7.4.1. Key Highlights 7.4.1.1. Brazil Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 7.4.1.2. Brazil Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 7.4.1.3. Brazil Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 7.4.1.4. Mexico Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 7.4.1.5. Mexico Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 7.4.1.6. Mexico Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 7.4.1.7. Argentina Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 7.4.1.8. Argentina Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 7.4.1.9. Argentina Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 7.4.1.10. Rest of Latin America Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 7.4.1.11. Rest of Latin America Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 7.4.1.12. Rest of Latin America Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 7.4.2. BPS Analysis/Market Attractiveness Analysis 8. Middle East & Africa Antibody Discovery Market Outlook, 2019 - 2032 8.1. Middle East & Africa Antibody Discovery Market Outlook, by Method, Value (US$ Bn), 2019 - 2032 8.1.1. Key Highlights 8.1.1.1. Phage Display 8.1.1.2. Hybridoma 8.1.1.3. Others 8.2. Middle East & Africa Antibody Discovery Market Outlook, by Antibody Type, Value (US$ Bn), 2019 - 2032 8.2.1. Key Highlights 8.2.1.1. Humanized Antibody 8.2.1.2. Human Antibody 8.2.1.3. Chimeric Antibody 8.2.1.4. Murine Antibody 8.3. Middle East & Africa Antibody Discovery Market Outlook, by End-use, Value (US$ Bn), 2019 - 2032 8.3.1. Key Highlights 8.3.1.1. Pharmaceutical and Biotechnology industry 8.3.1.2. Research laboratory 8.3.1.3. Academic laboratory 8.3.2. BPS Analysis/Market Attractiveness Analysis 8.4. Middle East & Africa Antibody Discovery Market Outlook, by Country, Value (US$ Bn), 2019 - 2032 8.4.1. Key Highlights 8.4.1.1. GCC Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 8.4.1.2. GCC Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 8.4.1.3. GCC Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 8.4.1.4. South Africa Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 8.4.1.5. South Africa Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 8.4.1.6. South Africa Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 8.4.1.7. Egypt Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 8.4.1.8. Egypt Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 8.4.1.9. Egypt Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 8.4.1.10. Nigeria Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 8.4.1.11. Nigeria Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 8.4.1.12. Nigeria Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 8.4.1.13. Rest of Middle East & Africa Antibody Discovery Market by Method, Value (US$ Bn), 2019 - 2032 8.4.1.14. Rest of Middle East & Africa Antibody Discovery Market by Antibody Type, Value (US$ Bn), 2019 - 2032 8.4.1.15. Rest of Middle East & Africa Antibody Discovery Market by End-use, Value (US$ Bn), 2019 - 2032 8.4.2. BPS Analysis/Market Attractiveness Analysis 9. Competitive Landscape 9.1. By Method vs by Antibody Type Heat map 9.2. Company Market Share Analysis, 2025 9.3. Competitive Dashboard 9.4. Company Profiles 9.4.1. Alcami Corporation, Inc. 9.4.1.1. Company Overview 9.4.1.2. Product Portfolio 9.4.1.3. Financial Overview 9.4.1.4. Business Strategies and Development 9.4.2. BASF SE 9.4.2.1. Company Overview 9.4.2.2. Product Portfolio 9.4.2.3. Financial Overview 9.4.2.4. Business Strategies and Development 9.4.3. Bioduro-Sundia 9.4.3.1. Company Overview 9.4.3.2. Product Portfolio 9.4.3.3. Financial Overview 9.4.3.4. Business Strategies and Development 9.4.4. Bruker 9.4.4.1. Company Overview 9.4.4.2. Product Portfolio 9.4.4.3. Financial Overview 9.4.4.4. Business Strategies and Development 9.4.5. Cambrex Corporation 9.4.5.1. Company Overview 9.4.5.2. Product Portfolio 9.4.5.3. Financial Overview 9.4.5.4. Business Strategies and Development 9.4.6. Croda International Plc 9.4.6.1. Company Overview 9.4.6.2. Product Portfolio 9.4.6.3. Financial Overview 9.4.6.4. Business Strategies and Development 9.4.7. Aragen Life Sciences Pvt. Ltd 9.4.7.1. Company Overview 9.4.7.2. Product Portfolio 9.4.7.3. Financial Overview 9.4.7.4. Business Strategies and Development 9.4.8. Eurofins DiscoverX Corporation 9.4.8.1. Company Overview 9.4.8.2. Product Portfolio 9.4.8.3. Financial Overview 9.4.8.4. Business Strategies and Development 9.4.9. NanoCellect Biomedical 9.4.9.1. Company Overview 9.4.9.2. Product Portfolio 9.4.9.3. Financial Overview 9.4.9.4. Business Strategies and Development 9.4.10. Sartorius AG 9.4.10.1. Company Overview 9.4.10.2. Product Portfolio 9.4.10.3. Financial Overview 9.4.10.4. Business Strategies and Development 10. Appendix 10.1. Research Methodology 10.2. Report Assumptions 10.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療IT）の最新刊レポート
Fairfield Market Research社のヘルスケアIT分野での最新刊レポート
本レポートと同じKEY WORD（antibody）の最新刊レポート
よくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
